Reuters Health Report: November 23, 2017

Click to View in Browser Thursday, November 23, 2017 Teva Pharmaceutical set for major layoffs in Israel, U.S.: report TEL AVIV (Reuters) - Teva Pharmaceutical Industries is expected to cut 20-25 percent of its 6,860 workers in Israel and a few thousand more in the United States, financial news website Calcalist reported on Thursday. Sign-up pace slows in third week of 2018 Obamacare enrollment (Reuters) - The pace slowed in the third week of enrollment for 2018 Obamacare individual insurance as nearly 800,000 people signed up through the federal government website HealthCare.gov, down about 75,000 people from the previous week, a U.S. government agency reported on Wednesday. U.S. judge strikes down Texas measure to limit second-trimester abortions AUSTIN, Texas (Reuters) - A U.S. district judge on Wednesday struck down parts of a Texas law that would ban the most common type of second-trimester abortions in the state, after plaintiffs argued the procedure was safe, legal and necessary for women's health. Bayer pharmaceuticals head says there's no pipeline problem LEVERKUSEN, Germany (Reuters) - Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces a threat to revenues in 2024 when the blockbuster heart drug Xarelto loses its patent. Three coffees a day linked to more health than harm: study LONDON (Reuters) - People who drink three to four cups of coffee a day are more likely to see health benefits than harm, experiencing lower risks of premature death and heart disease than those who abstain, scientists said on Wednesday. Exclusive: India pares back planned funding for crucial public health scheme NEW DELHI (Reuters) - India has approved a three-year budget for its flagship public health program almost 20 percent lower than what the health ministry said was needed, according to sources and previously unreported government documents reviewed by Reuters. Australia's Victoria state closer to legalizing assisted death SYDNEY (Reuters) - Australia's second-largest state on Wednesday took another step towards adopting a law allowing voluntary assisted dying for terminally ill patients. U.S. FDA approves first two-drug HIV regimen in win for GSK (Reuters) - The U.S. Food and Drug Administration has approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines. Many hospitals lack specialists for hand, face emergencies (Reuters Health) - In an emergency involving face or hand trauma, barely one in four hospitals can muster a specialist surgeon, a recent U.S. study suggests. Gold mining firms set aside $360 million for South Africa silicosis law suit CAPE TOWN (Reuters) - Six gold mining firms, including Anglo American, have made a 5 billion rand ($361 million) provision to settle a class action law suit with thousands of miners who contracted fatal lung diseases while working in South African mines, an industry document said on Wednesday. Related Video Edible glass made from seaweed to curb plastic plague Simple water test could prevent crippling bone disease A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook